H, P., M, P., M, G., J, R., A, B., M, K., . . . M, J. (2026). Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer. Clinical therapeutics, 48(1), 73. https://doi.org/10.1016/j.clinthera.2025.10.011
Παραπομπή σε μορφή Chicago (17η εκδ.)H, Pandya, et al. "Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer." Clinical Therapeutics 48, no. 1 (2026): 73. https://doi.org/10.1016/j.clinthera.2025.10.011.
Παραπομπή σε μορφή MLA (9th εκδ.)H, Pandya, et al. "Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer." Clinical Therapeutics, vol. 48, no. 1, 2026, p. 73, https://doi.org/10.1016/j.clinthera.2025.10.011.